MedPath

Minnesota Medicaid Incentives to Prevent Chronic Disease

Not Applicable
Completed
Conditions
Prediabetic State
Registration Number
NCT02422420
Lead Sponsor
Minnesota Department of Human Services
Brief Summary

The objective of this study is to test whether two different participant financial incentive structures are more effective and cost effective than minimal financial incentives in increasing weight loss among Minnesota Medicaid beneficiaries at high risk of developing diabetes. The incentives are tied to participation and weight loss in the evidence-based group-delivered YMCA diabetes prevention program (Y-DPP). The Investigators will conduct a group randomized trial that includes up to 150 Y-DPP classes of 10-15 participants per class for up to 1500 Medicaid beneficiaries participating in the Y-DPP classes. This approach, if successful, will (a) improve weight loss. diabetes risk, and improve cardiovascular risk among Medicaid beneficiaries at risk for developing diabetes and other chronic conditions, (b) demonstrate that prevention of chronic disease risk factors using patient incentives is cost-effective, and (c) provide a patient incentive model that can be widely used among Medicaid beneficiaries at risk for developing diabetes.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
1500
Inclusion Criteria
  • currently enrolled in Medical Assistance, PMAP, or MinnesotaCare (collectively referred to as Medicaid)
  • 18-75 years of age
  • body mass index ≥ 25 kg/m2 (≥ 22 kg/m2 for those of Asian descent)
  • have prediabetes or a history of gestational diabetes mellitus (GDM)
Exclusion Criteria
  • diagnosis of diabetes
  • pregnant at the time of enrollment
  • planning gastric bypass surgery within the next 12 months
  • diagnosed with Alzheimer's disease (ICD-9 331.0) or dementia (ICD-9 290.0 - 294.9)
  • provider judgment regarding suitability for the study based on substance abuse, uncontrolled mental illness, or other conditions that may affect the participants health or ability to participate in the study.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
DPP Attendance12 months

Participation in DPP core and post-core sessions

Weight Change12 months

Change in participants' weight

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Minnesota Department of Health

🇺🇸

St. Paul, Minnesota, United States

Minnesota Department of Health
🇺🇸St. Paul, Minnesota, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.